Serotonergic component of SCH 23390: in vitro and in vivo binding analyses. (Q48160093)

9 February 2018

title

Serotonergic component of SCH 23390: in vitro and in vivo binding analyses. (English)

1 reference

9 February 2018

author name string

McQuade RD

1

1 reference

9 February 2018

Ford D

2

1 reference

9 February 2018

Duffy RA

3

1 reference

9 February 2018

Chipkin RE

4

1 reference

9 February 2018

Iorio LC

5

1 reference

9 February 2018

Barnett A

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 January 1988

1 reference

9 February 2018

published in

Life Sciences

1 reference

9 February 2018

volume

43

1 reference

9 February 2018

issue

23

1 reference

9 February 2018

page(s)

1861-1869

1 reference

9 February 2018

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

SCH 23390—The first selective dopamine D-1 antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

5-Hydroxytryptamine can antagonize the ability of metoclopramide and SCH 23390 to enhance electrical field stimulation-evoked contractions of guinea-pig isolated stomach muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

Characterization of the radioiodinated analogue of SCH 23390: in vitro and in vivo D-1 dopamine receptor binding studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980003-1

10.1016/S0024-3205(88)80003-1

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

2904635

1 reference

9 February 2018